In topline results from the phase 3 SUMMIT study, Lillys dual GIP/GLP-1 receptor agonist tirzepatide cut the risk of heart failure Today, Lilly announced promising data for the SURMOUNT-OSA phase 3 clinical trials testing tirzepatide in adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity
That is why our synthesis process involves rigorous filtration and lyophilization to maintain a 99%+ purity profile
It simultaneously activates two receptor pathways that regulate blood sugar, appetite, and energy metabolism
Clinical trials establishing semaglutide efficacy used this tiered approach intentionally, allowing metabolic adaptation and early identification of individual tolerability
Key points: Melanotan-II is being increasingly promoted on platforms like TikTok and YouTube The drug has been promoted as a product that can give its users a tan, but it can have serious health risks The TGA is targeting social media influencers and warning of big fines for people who are promoting dangerous products Last month the Therapeutic Goods Administration (TGA) issued a warning about Melanotan-II, a substance being widely spruiked on social media platforms such as TikTok and Instagram
This can increase your risk of diabetic complications including cardiovascular disease, neuropathy, nephropathy, and retinopathy
